Developmental neuroscience

New book charts one family’s journey untangling the mysteries of regression, diagnosis and recovery

Retrieved on: 
Wednesday, November 4, 2020

Here, debuting author Ellen Woodbriar shares her experiences advocating for her son while navigating the mysteries of developmental regression and the complexities of diagnosis and recovery.

Key Points: 
  • Here, debuting author Ellen Woodbriar shares her experiences advocating for her son while navigating the mysteries of developmental regression and the complexities of diagnosis and recovery.
  • His developmental journey started out smoothly with the typical colds and viruses that all toddlers get.
  • This is the story of Jackson's regression, ultimate diagnosis, medical intervention, therapies and recovery over a 12-year period.
  • This book is also intended to provide practical resources and references to any reader working with a complex medical diagnosis.

H2 2020 Pipeline Review for Beta Nerve Growth Factor - ResearchAndMarkets.com

Retrieved on: 
Friday, October 16, 2020

The "Beta Nerve Growth Factor - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Beta Nerve Growth Factor - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • Beta Nerve Growth Factor (Beta NGF or NGF) pipeline Target constitutes close to 10 molecules.
  • The latest report Beta Nerve Growth Factor - Pipeline Review, H2 2020, outlays comprehensive information on the Beta Nerve Growth Factor (Beta NGF or NGF) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.
  • Beta Nerve Growth Factor (Beta NGF or NGF) - Nerve growth factor is a neurotrophic factor involved in the regulation of growth, maintenance, proliferation, and survival of certain target neurons.

Leading autism expert Dr. Temple Grandin, autistic herself, keynote speaker for MacDonald Training Center fundraiser

Retrieved on: 
Friday, October 9, 2020

Dr. Grandin is a sought-after public speaker, and frequent presenter on TED Talks, where her most recent topic was "The World Needs All Kinds of Minds."

Key Points: 
  • Dr. Grandin is a sought-after public speaker, and frequent presenter on TED Talks, where her most recent topic was "The World Needs All Kinds of Minds."
  • In 2020, the CDC reported that approximately 1 in 54 children in the U.S. is diagnosed with an autism spectrum disorder (ASD), according to 2016 data.
  • Boys are four times more likely to be diagnosed with autism than girls.
  • In fact, the trend has been steeply upward since the early 1990s, not only in the U.S. but globally.

2 New Autism Therapy Centers Open in Colorado

Retrieved on: 
Wednesday, September 30, 2020

With over 50 locations across Texas, Oklahoma, and Colorado, Behavioral Innovations has established itself as a leading services provider for children with Autism Spectrum Disorder (ASD).

Key Points: 
  • With over 50 locations across Texas, Oklahoma, and Colorado, Behavioral Innovations has established itself as a leading services provider for children with Autism Spectrum Disorder (ASD).
  • Along with their other centers in East Littleton and Commerce City, the company hopes to provide greater ease of access for families in the Denver metro area.
  • These are taught in a fun and interactive environment at their centers to help every child reach their potential.
  • People can follow them on Facebook and Instagram to receive regular updates on ABA Therapy and autism resources.

Therapeutic Solutions International Reports Positive Preclinical Data on JadiCell™ Universal Donor Stem Cell Therapy for Brain Injury

Retrieved on: 
Monday, September 28, 2020

OCEANSIDE, Calif., Sept. 28, 2020 /PRNewswire/ -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI), reported today positive preclinical data demonstrating superior neuro-regenerative activity to other cell therapies such as mesenchymal stem cells.

Key Points: 
  • OCEANSIDE, Calif., Sept. 28, 2020 /PRNewswire/ -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI), reported today positive preclinical data demonstrating superior neuro-regenerative activity to other cell therapies such as mesenchymal stem cells.
  • Using animal models, Company collaborators demonstrated stimulation of stem cell proliferation that reside in parts of the brain called the "dentate gyrus".
  • Additionally, the Company reported protection of neurons from inflammation associated cell death as well as reduction of inflammatory proteins produced by brain cells called "microglia".
  • "Brain injury in the form of Chronic Traumatic Encephalopathy is a major scourge on the bravest elements of our society: the veterans.

Bionano to Present at the September 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Retrieved on: 
Monday, September 21, 2020

A replay of the webcast presentation will be posted under the Investor Relations section of Bionanos website following the live event.

Key Points: 
  • A replay of the webcast presentation will be posted under the Investor Relations section of Bionanos website following the live event.
  • Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business.
  • Lineagen has been providing genetic testing services to families and their healthcare providers for over nine years and has performed over 65,000 tests for those with neurodevelopmental concerns.
  • For more information, visit www.bionanogenomics.com or www.lineagen.com .

Hopebridge Expands Pediatric Autism Therapy Centers in Colorado

Retrieved on: 
Monday, September 21, 2020

Indianapolis, Ind., Sept. 21, 2020 (GLOBE NEWSWIRE) -- To meet the growing need for autism services across the country, Hopebridge Autism Therapy Centers, one of the largest autism therapy networks in the nation, is expanding its innovative interdisciplinary care into Colorado with six new Denver area locations starting in October 2020.

Key Points: 
  • Indianapolis, Ind., Sept. 21, 2020 (GLOBE NEWSWIRE) -- To meet the growing need for autism services across the country, Hopebridge Autism Therapy Centers, one of the largest autism therapy networks in the nation, is expanding its innovative interdisciplinary care into Colorado with six new Denver area locations starting in October 2020.
  • In an effort to reduce wait times, Hopebridge is currently scheduling diagnostic assessments for autism spectrum disorder (ASD) and applied behavior analysis (ABA) therapy evaluations for all six locations.
  • In addition, more than 33% of Colorado children with autism had to wait longer than six months to get their diagnosis.
  • These six Hopebridge Colorado centers will ultimately create more than 325 new jobs throughout the state to ensure every child with autism receives one-on-one, personalized therapy.

New Resource for Children with Autism Opens This Week in Eastern Madison

Retrieved on: 
Thursday, September 10, 2020

MADISON, Wis., Sept. 10, 2020 /PRNewswire/ -- Caravel Autism Health is opening the doors to a new autism center for children in Madison, WI this week.

Key Points: 
  • MADISON, Wis., Sept. 10, 2020 /PRNewswire/ -- Caravel Autism Health is opening the doors to a new autism center for children in Madison, WI this week.
  • The new center, located on Madison's east side at 4005 Felland Road, provides services for children with autism and their families.
  • Founded by clinicians who specialize in working with children with autism, Caravel Autism Health has its roots in Wisconsin.
  • Caravel's team of autism health experts specializes in the evaluation, diagnosis and treatment of children on the autism spectrum.

Behavioral Therapy expands into Colorado with New Autism Centers

Retrieved on: 
Wednesday, September 9, 2020

With 48 locations in Texas, Oklahoma, and Colorado, Behavioral Innovations has been serving the needs of children with Autism Spectrum Disorder (ASD) for the past 20 years.

Key Points: 
  • With 48 locations in Texas, Oklahoma, and Colorado, Behavioral Innovations has been serving the needs of children with Autism Spectrum Disorder (ASD) for the past 20 years.
  • Their centers provide 1-to-1 personalized treatment plans that include a fun, interactive, and naturalistic teaching environment to help every child reach their potential.
  • Behavioral Innovations credentials their clinical staff to strict BACB protocols and holds all staff accountable to the high BACB standards.
  • People can follow them on Facebook and Instagram to receive regular updates on ABA Therapy and autism resources.

Kanazawa University research: Repulsion mechanism between neurons governs fly brain structure

Retrieved on: 
Monday, September 7, 2020

KANAZAWA, Japan, Sept. 7, 2020 /PRNewswire/ -- Researchers at Kanazawa University report in Nature Communications the discovery that in the developing fly brain, neurons stemming from the same parent cell experience repulsion.This lineage-dependent repulsion is regulated by a protein known as Dscam1.

Key Points: 
  • KANAZAWA, Japan, Sept. 7, 2020 /PRNewswire/ -- Researchers at Kanazawa University report in Nature Communications the discovery that in the developing fly brain, neurons stemming from the same parent cell experience repulsion.This lineage-dependent repulsion is regulated by a protein known as Dscam1.
  • The brain's structure has columnar features, which are hypothesized to arise from nerve cells (neurons) stemming from the same parent cell, initially forming radial units.
  • (Axons or nerve fibers are long protrusions of nerve cells, the function of which is to conduct electrical signals).This finding corroborates the 'radial unit hypothesis', with the mechanism at play being lineage-dependent repulsion between sister neurons.
  • Dscam1 establishes the columnar units through lineage-dependent repulsion between sister neurons in the fly brain, Nature Communications 11, 4067 (2020).